C.Q.Pharmaceutical Holding000950.SZValuation Analysis

As of Oct 19, 2026, C.Q.Pharmaceutical Holding (000950.SZ) trades at a P/E of 24.70x, P/B of 0.75x, P/S of 0.11x, and a dividend yield of 1.16%.
Longitudinal percentile comparison: P/E sits at the 82nd percentile over the trailing 10Y window (vs. 54th percentile over 3Y); P/B sits at the 5th percentile over the trailing 10Y window (vs. 16th percentile over 3Y); P/S sits at the 12th percentile over the trailing 10Y window (vs. 38th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 30th percentile within its industry and the 34th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.08%, ranking at the 91st percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 76.4 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 2.08% total shareholder yield, 1.16% is paid out as dividends and roughly 0.91% is implied to come from buybacks — both channels are meaningfully in play. C.Q.Pharmaceutical Holding operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.